Failure of recombinant factor VIIa in a patient with severe polymicrobial sepsis and postoperative uncontrolled intraabdominal bleeding

BMC Infectious Diseases

Volumn 7, Issue , 2007, Pages

  Conen, Anna ^a   Weisser, Maja ^a   Tsakiris, Dimitrios A ^a   Siegemund, Martin ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BLOOD CLOTTING FACTOR 8 CONCENTRATE; ENALAPRIL PLUS HYDROCHLOROTHIAZIDE; FLUCONAZOLE; FRESH FROZEN PLASMA; HAEMATE; HEPARIN; MEROPENEM; METFORMIN; PIPERACILLIN PLUS TAZOBACTAM; PROTAMINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOCYTE CONCENTRATE; TRANEXAMIC ACID; UNCLASSIFIED DRUG; VASOACTIVE AGENT; BLOOD CLOTTING FACTOR 7A; COAGULATING AGENT; RECOMBINANT PROTEIN;

ABDOMINAL BLEEDING; ABDOMINAL SURGERY; ADULT; ARTICLE; BACTEROIDES FRAGILIS; BLOOD CULTURE; BLOOD TRANSFUSION; CANDIDA ALBICANS; CASE REPORT; COLON DIVERTICULOSIS; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; DRUG MEGADOSE; DRUG MONITORING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHROCYTE; ESCHERICHIA COLI; HEMOFILTRATION; HEMORRHAGIC SHOCK; HUMAN; KLEBSIELLA OXYTOCA; MALE; MULTIPLE ORGAN FAILURE; OFF LABEL DRUG USE; POSTOPERATIVE HEMORRHAGE; SEPSIS; SEPTIC SHOCK; ABDOMEN; ABDOMINAL RADIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; FATALITY; GENETICS; MICROBIOLOGY; MIDDLE AGED; RADIOGRAPHY; TREATMENT FAILURE;

ABDOMEN; COAGULANTS; FACTOR VIIA; FATAL OUTCOME; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RADIOGRAPHY, ABDOMINAL; RECOMBINANT PROTEINS; SEPSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT FAILURE;

EID: 34249737463     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-7-34     Document Type: Article

References (23)

1. Hedner U Glazer S Pingel K Alberts KA Blomback M Schulman S Johnsson H Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy Lancet 1988 2 8621 1193 10.1016/ S0140-6736(88)90259-0 2903400
2. Macik BG Hohneker J Roberts HR Griffin AM Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitor Am J Hematol 1989 32 3 232-234 10.1002/ajh.2830320315 2816918
3. Hedner U Factor VIIa in the treatment of haemophilia Blood Coagul Fibrinolysis 1990 1 3 307-317 2103315
4. Ghorashian S Hunt BJ "Off-license" use of recombinant activated factor VII Blood Rev 2004 18 4 245-259 10.1016/ j.blre.2003.12.003 15501553
5. Paganoni R Off-label-Indikation von rekombinantem aktiviertem Faktor VII (rFVIIa, NovoSeven®), issued by Swiss Society for Intensive Care Medicine www.swiss-icu.ch/NovoSeven_V07.pdf 2005
6. Martinowitz U Michaelson M Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: A report by the Israeli Multidisciplinary rFVIIa Task Force J Thromb Haemost 2005 3 4 640-648 10.1111/j.1538-7836.2005.01203.x 15842347
7. Mayer SA Brun NC Begtrup K Broderick J Davis S Diringer MN Skolnick BE Steiner T Recombinant activated factor VII for acute intracerebral hemorrhage N Engl J Med 2005 352 8 777-785 10.1056/NEJMoa042991 15728810
8. Boffard KD Riou B Warren B Choong PI Rizoli S Rossaint R Axelsen M Kluger Y Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials J Trauma 2005 59 1 8-15; discussion 15-8 16096533
9. Pihusch M Bacigalupo A Szer J von Depka Prondzinski M Gaspar-Blaudschun B Hyveled L Brenner B Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation J Thromb Haemost 2005 3 9 1935-1944 10.1111/j.1538-7836.2005.01523.x 16102099
10. Planinsic RM van der Meer J Testa G Grande L Candela A Porte RJ Ghobrial RM Isoniemi H Schelde PB Erhardtsen E Klintmalm G Emre S Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease Liver Transpl 2005 11 8 895-900 10.1002/lt.20458 16035081
11. Hedner U Dosing and monitoring NovoSeven treatment Haemostasis 1996 26 Suppl 1 102-108 8904183
12. Stein DM Dutton RP O'Connor J Alexander M Scalea TM Determinants of Futility of Administration of Recombinant Factor VIIa in Trauma J Trauma 2005 59 3 609-615 16361902
13. Meng ZH Wolberg AS Monroe DM 3rd Hoffman M The effect of temperature and pH on the activity of factor VIIa: Implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients J Trauma 2003 55 5 886-891 14608161
14. Clark AD Gordon WC Walker ID Tait RC 'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective Vox Sang 2004 86 2 120-124 10.1111/j.0042-9007.2004.00393.x 15023181
15. Levi M Disseminated intravascular coagulation: What's new? Crit Care Clin 2005 21 3 449-467 10.1016/j.ccc.2005.02.001 15992667
16. Moscardo F Perez F de la Rubia J Balerdi B Lorenzo JI Senent ML Aznar I Carceller S Sanz MA Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII Br J Haematol 2001 114 1 174-176 10.1046/j.1365-2141.2001.02878.x 11472364
17. Martinez J Cid AR de la Rubia J Gimeno R Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock Blood Coagul Fibrinolysis 2005 16 4 297-299 15870551
18. Sallah S Husain A Nguyen NP Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated intravascular coagulation Blood Coagul Fibrinolysis 2004 15 7 577-582 15389125
19. Eller P Pechlaner C Wiedermann CJ Ineffective off-label use of recombinant activated factor VII in a case of bone-marrow transplantation-related gastrointestinal bleeding Thromb J 2006 4 1 1 1373608 16420687 10.1186/1477-9560-4-1
20. Levi M Peters M Buller HR Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review Crit Care Med 2005 33 4 883-890 10.1097/01.CCM.0000159087.85970.38 15818119
21. O'Connell KA Wood JJ Wise RP Lozier JN Braun MM Thromboembolic adverse events after use of recombinant human coagulation factor VIIa Jama 2006 295 3 293-298 10.1001/jama.295.3.293 16418464
22. Pusateri AE Park MS Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma Crit Care 2005 9 Suppl 5 S15-24 10.1186/cc3781 16221315
23. Sorensen B Ingerslev J Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography Haemophilia 2005 11 Suppl 1 1-6 10.1111/ j.1365-2516.2005.01156.x 16219042